ArticleInfectious Disease Modelling2025
Comparative assessment of airborne infection risk tools in enclosed spaces: Implications for disease control.
Article in Infectious Disease Modelling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Mathematical Modeling of Viral RNA Copies in Indoor Environments: Pre-Processor for Risk Assessment and Decision-Making Support Tool for Public Health.Risk analysis : an official publication of the Society for Risk Analysis · 2026Article
- Aerosol emission rates from breathing, speaking, and speaking with a surgical mask.Frontiers in public health · 2026Article
- A New Method Proposed for Analyzing Airflow Dynamics in Negative Pressure Isolation Chambers Using Particle Image Velocimetry.Bioengineering (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic, caused by SARS-CoV-2, highlighted the importance of understanding transmission modes and implementing effective mitigation strategies. Recognizing airborne transmission as a primary route has reshaped public health measures, emphasizing the need to optimize indoor environments to reduce risks. Numerous tools have emerged to assess airborne infection risks in enclosed spaces, providing valuable resources for public health authorities, researchers, and the general public. However, comparing the outputs of these tools is challenging because of variations in assumptions, mathematical models, and data sources. We conducted a comprehensive review, comparing digital airborne infection risk calculators using standardized building-specific input parameters. These tools generally produce similar and consistent outputs with identical inputs. Variations mainly stem from model selection and the handling of unsteady viral load conditions. Differences in source term calculations, including particle emission concentrations and respiratory activity, also contribute to disparities. These differences are minor compared to the inherent uncertainties in risk assessment. Consistency in results increases with higher ventilation rates, showing a robust trend across models. However, inconsistencies arose in the inclusion of face masks, often due to the lack of detailed efficiency values. Despite some differences, the overall consistency underscores the value of these tools in public health strategy and infectious disease control. We also compared some of the model's efforts to conduct retrospective assessments against reported transmission events by assuming input parameters to the models so that the calculated risk would closely fit the original outbreak infection rate. Thus, validating these models against past outbreaks remains challenging because of the lack of essential input information from observed events. This comparative analysis demonstrates the importance of transparent data sources and justifiable model assumptions to enhance the reliability and precision of risk assessments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.